AAAAAA

   
Results: 1-16 |
Results: 16
A HIGHLY SPECIFIC FUNCTIONAL TEST FOR FACTOR-V-LEIDEN - A MODIFIED TISSUE FACTOR ASSAY FOR ACTIVATED PROTEIN-C RESISTANCE
Authors: ARKEL YS KU DH KAMIYAMA M PAJARO R ALDER H MARCHAND A
Citation: Ys. Arkel et al., A HIGHLY SPECIFIC FUNCTIONAL TEST FOR FACTOR-V-LEIDEN - A MODIFIED TISSUE FACTOR ASSAY FOR ACTIVATED PROTEIN-C RESISTANCE, Haemostasis, 27(6), 1997, pp. 290-304
COMPARISON OF THE FUNCTIONAL PLATELET-AGGREGATION AND ATP RELEASE ANDHEPARIN-PLATELET FACTOR 4 ANTIBODY ELISA METHODS IN THE TESTING FOR THE HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME
Authors: ARKEL YS KU DH LAKRA J LAM X
Citation: Ys. Arkel et al., COMPARISON OF THE FUNCTIONAL PLATELET-AGGREGATION AND ATP RELEASE ANDHEPARIN-PLATELET FACTOR 4 ANTIBODY ELISA METHODS IN THE TESTING FOR THE HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME, Blood, 90(10), 1997, pp. 3200-3200
THE EFFECT OF LUPUS INHIBITOR PLASMA ON THE ACTION OF ACTIVATED PROTEIN-C IN THE DEGRADATION OF FACTOR VA
Authors: ARKEL YS KU DH
Citation: Ys. Arkel et Dh. Ku, THE EFFECT OF LUPUS INHIBITOR PLASMA ON THE ACTION OF ACTIVATED PROTEIN-C IN THE DEGRADATION OF FACTOR VA, Blood, 90(10), 1997, pp. 3201-3201
FACTOR-V-LEIDEN AND ACUTE ARTERIAL THROMBOTIC DISEASE
Authors: ARKEL YS KU DH GIBSON D
Citation: Ys. Arkel et al., FACTOR-V-LEIDEN AND ACUTE ARTERIAL THROMBOTIC DISEASE, Blood, 90(10), 1997, pp. 3202-3202
PROTHROMBIN GENE MUTATION-20210 ASSOCIATED WITH THROMBOTIC EVENT IN THE UNUSUAL SITE
Authors: ARKEL YS KU DH
Citation: Ys. Arkel et Dh. Ku, PROTHROMBIN GENE MUTATION-20210 ASSOCIATED WITH THROMBOTIC EVENT IN THE UNUSUAL SITE, Blood, 90(10), 1997, pp. 3203-3203
A SPECIFIC TEST FOR FACTOR-V LEIDEN USING A TISSUE FACTOR ASSAY WITH THE ADDITION OF PHOSPHOLIPID
Authors: ARKEL YS KU DHW ALDER H MARCHAND A
Citation: Ys. Arkel et al., A SPECIFIC TEST FOR FACTOR-V LEIDEN USING A TISSUE FACTOR ASSAY WITH THE ADDITION OF PHOSPHOLIPID, Circulation, 94(8), 1996, pp. 4338-4338
USE OR A RECOMBINANT TISSUE FACTOR DERIVED ACTIVATED FACTOR-VII LEVELS AS A MARKER FOR HYPERCOAGUABILITY
Authors: ARKEL YS KU DH
Citation: Ys. Arkel et Dh. Ku, USE OR A RECOMBINANT TISSUE FACTOR DERIVED ACTIVATED FACTOR-VII LEVELS AS A MARKER FOR HYPERCOAGUABILITY, Blood, 88(10), 1996, pp. 3042-3042
FACTOR-V ASSAY AS A FUNCTIONAL TEST FOR THE FACTOR-V LEIDEN RESISTANCE TO ACTIVATED PROTEIN-C SYNDROME
Authors: ARKEL YS KU DH KAMIYAMA M PAJARO R ALDER H MARCHAND A
Citation: Ys. Arkel et al., FACTOR-V ASSAY AS A FUNCTIONAL TEST FOR THE FACTOR-V LEIDEN RESISTANCE TO ACTIVATED PROTEIN-C SYNDROME, Blood, 86(10), 1995, pp. 797-797
ACQUIRED VON WILLEBRANDS-SYNDROME IN ASSOCIATION WITH A LUPUS-LIKE ANTICOAGULANT CORRECTED BY INTRAVENOUS IMMUNOGLOBULIN
Authors: HANLEY D ARKEL YS LYNCH J KAMIYAMA M
Citation: D. Hanley et al., ACQUIRED VON WILLEBRANDS-SYNDROME IN ASSOCIATION WITH A LUPUS-LIKE ANTICOAGULANT CORRECTED BY INTRAVENOUS IMMUNOGLOBULIN, American journal of hematology, 46(2), 1994, pp. 141-146
TREATMENT OF ACQUIRED VON WILLEBRAND SYNDROME WITH INTRAVENOUS IMMUNOGLOBULIN
Authors: ARKEL YS LYNCH J KAMIYAMA M
Citation: Ys. Arkel et al., TREATMENT OF ACQUIRED VON WILLEBRAND SYNDROME WITH INTRAVENOUS IMMUNOGLOBULIN, Thrombosis and haemostasis, 72(4), 1994, pp. 643-644
PATIENT WITH CARDIAC VALVULAR DISEASE, LUPUS INHIBITOR, ANTICARDIOLIPIN ANTIBODIES, HEPARIN-INDUCED THROMBOCYTOPENIA, DEEP-VEIN THROMBOSIS AND CARDIOCEREBRAL EMBOLIZATION
Authors: ARKEL YS LYNCH J VINCENT D KAMIYAMA M
Citation: Ys. Arkel et al., PATIENT WITH CARDIAC VALVULAR DISEASE, LUPUS INHIBITOR, ANTICARDIOLIPIN ANTIBODIES, HEPARIN-INDUCED THROMBOCYTOPENIA, DEEP-VEIN THROMBOSIS AND CARDIOCEREBRAL EMBOLIZATION, Blood, 84(10), 1994, pp. 10000692-10000692
A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
Authors: BRAY GL GOMPERTS ED COURTER S GRUPPO R GORDON EM MANCOJOHNSON M SHAPIRO A SCHEIBEL E WHITE G LEE M GORDON M BERTALONE S LIPTON R HILGARTNER M ARKIN S GILL J KIM H SHURIN S SANTIAGOBORRERO P ARKEL YS KULKARNI R GREENWOOD MF RITCHEY AK WERNER E HAIRE WD KISKER T NEUFELD E EWENSTEIN B DEBIASI R LAURIAN Y KREUZ W RODEGHIERO F INGERSLEV J GAZENGEL C DIMICHELE D COOPER H
Citation: Gl. Bray et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Blood, 83(9), 1994, pp. 2428-2435
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN ON INHIBITION OF FIBRINOGEN BINDING TO PLATELETS BY SERA FROM PATIENTS WITH IMMUNE THROMBOCYTOPENIA
Authors: KAMIYAMA M YOSHIMURA Y CHEN K ARKEL YS
Citation: M. Kamiyama et al., EFFECT OF INTRAVENOUS IMMUNOGLOBULIN ON INHIBITION OF FIBRINOGEN BINDING TO PLATELETS BY SERA FROM PATIENTS WITH IMMUNE THROMBOCYTOPENIA, American journal of hematology, 44(2), 1993, pp. 77-84
PSEUDOTHROMBOCYTOPENIA ASSOCIATED WITH IGG ANTIBODY WHICH CAUSES PLATELET ACTIVATION AND AGGLUTINATION MEDIATED BY VON-WILLEBRAND-FACTOR ORFIBRINOGEN
Authors: KAMIYAMA M ARKEL YS PAN P LYNCH J
Citation: M. Kamiyama et al., PSEUDOTHROMBOCYTOPENIA ASSOCIATED WITH IGG ANTIBODY WHICH CAUSES PLATELET ACTIVATION AND AGGLUTINATION MEDIATED BY VON-WILLEBRAND-FACTOR ORFIBRINOGEN, Thrombosis and haemostasis, 69(6), 1993, pp. 1336-1336
INHIBITION OF FIBRINOGEN BINDING TO PLATELET GPIIB IIIA BY IGM AND IGM IMMUNE-COMPLEXES/
Authors: KAMIYAMA M SHIDO K LYNCH J ASLAM T ARKEL YS
Citation: M. Kamiyama et al., INHIBITION OF FIBRINOGEN BINDING TO PLATELET GPIIB IIIA BY IGM AND IGM IMMUNE-COMPLEXES/, Blood, 82(10), 1993, pp. 10000594-10000594
INCREASED EXPOSURE OF PLATELET FC-RECEPTORS ASSOCIATED WITH PLATELET ACTIVATION
Authors: KAMIYAMA M SHIDO K PAN P ARKEL YS
Citation: M. Kamiyama et al., INCREASED EXPOSURE OF PLATELET FC-RECEPTORS ASSOCIATED WITH PLATELET ACTIVATION, Blood, 82(10), 1993, pp. 10000605-10000605
Risultati: 1-16 |